[HTML][HTML] Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - Trials, 2016 - Springer
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - 2016 - figshare.utas.edu.au
Background: Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - 2016 - pubmed.ncbi.nlm.nih.gov
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500-6000 male births. Despite broad research aiming to improve muscle …

[HTML][HTML] Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva… - …, 2016 - trialsjournal.biomedcentral.com
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that affects 1 in 3500–
6000 male births. Despite broad research aiming to improve muscle function as well as …

[PDF][PDF] Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - 2016 - d-nb.info
Background: Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - Trials, 2016 - search.proquest.com
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

[PDF][PDF] Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - 2016 - researchgate.net
Background: Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - Trials, 2016 - infona.pl
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

[HTML][HTML] Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - Trials, 2016 - ncbi.nlm.nih.gov
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500–6000 male births. Despite broad research aiming to improve muscle …

Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.

P Hafner, U Bonati, D Rubino, V Gocheva, T Zumbrunn… - Trials, 2016 - europepmc.org
Background Duchenne muscular dystrophy (DMD) is an X-linked recessive disease that
affects 1 in 3500-6000 male births. Despite broad research aiming to improve muscle …